Do pathogens accelerate atherosclerosis?

Area of Science:

• * Infectious disease
• * Vascular biology
• * Virology

Background:

• * Pathogens like human cytomegalovirus (HCMV) and Chlamydia pneumonia (CP) are implicated in vascular diseases such as atherosclerosis.
• * The role of infectious agents in vasculopathies remains debated, though animal models and clinical studies suggest a link.
• * Vascular disease involves injury, inflammation, and smooth muscle cell (SMC) proliferation/migration, leading to vessel narrowing.

Purpose of the Study:

• * To review evidence linking CP and HCMV to vascular disease development.
• * To propose a mechanism for HCMV's acceleration of vascular disease.
• * To investigate the role of HCMV infection in SMC migration.

Main Methods:

• * Review of existing literature on CP, HCMV, and vascular disease.
• * In vitro studies using arterial and venous smooth muscle cells (SMCs).
• * Analysis of HCMV-encoded chemokine receptor (US28) expression and its role in SMC migration.

Main Results:

• * HCMV infection of arterial SMCs, but not venous SMCs, induced significant cellular migration in vitro.
• * This migration was dependent on the HCMV-encoded US28 receptor and chemokines RANTES or MCP-1.
• * Demonstrated viral induction of SMC migration via a virally encoded chemokine receptor.

Conclusions:

• * HCMV infection can directly induce arterial SMC migration, a critical step in vascular disease.
• * The virally encoded US28 receptor plays a key role in HCMV-mediated SMC migration.
• * Provides a molecular mechanism linking HCMV to the development of vascular disease.